Neuromuscular diseases
Dystrophinopathies:
Duchenne
muscular dystrophy (DMD) Duchenne muscular dystrophy is the most common muscular dystrophy affecting
1 in 3500 boys born worldwide. Although the name Duchenne is inextricably linked to the most common childhood muscular dystrophy,
it was Gowers who recognized Sir Charles Bell for providing the first clinical description of Duchenne dystrophy in his 1830
publication.
Dystrophin protein is integral to the structural stability of
the myofiber. Without dystrophin, muscles are susceptible to mechanical injury and undergo repeated cycles of necrosis and
regeneration.
Dystrophin protein is
encoded by the largest gene described to date. It occupies almost 2% of the X chromosome and nearly 0.05% of the entire genome.
The gene consists of 79 exons and 8 promoters spread over 2.2 million base pairs of genomic DNA. It is expressed mainly in
smooth, cardiac, and skeletal muscle, with lower levels in the brain. In muscle, dystrophin is expressed as a
427-kd protein that consists of 2 apposed globular heads with a flexible rod-shaped center that links the intracellular actin
cytoskeleton to the extracellular matrix via the dystroglycan complex. The protein is organized into 4 structural domains
including the amino-terminal actin-binding domain, a central rod domain, a cysteine-rich domain, and a carboxy-terminal domain.
Its amino terminal end insinuates with the subsarcolemmal actin filaments of myofibrils, while cysteine-rich domains of the
carboxy-terminal end associate with beta-dystroglycan as well as elements of the sarcoglycan complex, all of which are contained
within the sarcolemmal membrane. Beta-dystroglycan in turn anchors the entire complex to the basal lamina via laminin. Epidemiology:Sex- Duchenne and Becker muscular dystrophy almost exclusively affect males
because of the X-linked inheritance pattern.
- Rarely, skewed random inactivation of healthy copies of the X chromosome leads to the Becker/Duchenne
phenotype in females who carry the dystrophin mutation.
- Females with Turner syndrome (XO) or uniparental disomy or those who have translocations
between the X and autosomal chromosomes may similarly manifest the Duchenne phenotype. Elevations of creatine phosphokinase
(CPK) level are found in two thirds of female carriers, the vast majority of whom are clinically asymptomatic.
Age- Duchenne
muscular dystrophy clinically manifests in patients aged 3-7 years, with development of lordosis, a waddling gait, and the
Gowers sign. Calf pseudohypertrophy follows 1-2 years later. Most patients are wheelchair bound by age 12 years.
History- Waddling gait,
manifesting in children aged 2-6 years, is often the first symptom in patients with Duchenne muscular dystrophy and is secondary
to hip girdle muscle weakness.
- Sometimes a young boy may come to medical attention because of elevated liver function enzymes (AST,
ALT), and in such cases serum creatine kinases CK and GGT levels should be checked prior to considering liver biopsies. Occasionally
a young boy may be referred for speech delay or learning problems.
- Most children with dystrophinopathy have IQs about one standard
deviation lower than the general population, but certainly plenty of exceptions exist. The low intellectual skills, such as
cognitive issues (learning differences, attention deficit hyperactivity disorder, obsessive-compulsive disorder, pervasive developmental disorder, mentalretardation), are seen in up to 30% of patients with dystrophinopathy.
- In some older boys , dilated cardiomyopathy findings may lead to
diagnoses such as viral or idiopathic cardiomyopathy when in fact a dystrophin mutation may be the underlying reason.
Laboratory
StudiesSerum creatine phosphokinase (CPK) Imaging Studies- Scoliosis frequently ensues in patients with Duchenne muscular dystrophy, particularly after
they are wheelchair dependent. Radiographs of the spine are important for screening and evaluating the degree of scoliotic
deformity.
Electromyography- Electromyography
(EMG), even though not diagnostic, narrows the differential diagnosis by effectively excluding primarily neurogenic processes
such as spinal muscular atrophy.
- In general, the proximal muscles of the lower extremities may exhibit the more prominent EMG findings.
A sufficient number of muscles need to be sampled to establish the presence of a diffuse process such as a dystrophy. The
more revealing findings will be obtained in muscles of intermediate involvement with respect to weakness.
- The motor unit action potentials (MUAPs)
in patients with Duchenne or Becker muscular dystrophy are typically of short duration, particularly the simple (ie, nonpolyphasic)
MUAPs. MUAP amplitudes are variable (normal to reduced) and they are typically polyphasic from the variability in muscle fiber
diameters, resulting in longer MUAP durations. Early recruitment of MUAPs may be seen. If muscle fiber loss is severe, then
what appears to be a loss of motor units may be seen with fast firing individual spikes. The latter are distinguished from
neurogenic processes by their generally lower-than-normal amplitudes and reduced area of spikes.
- Fibrillation potentials and positive sharp
waves, which represent spontaneously depolarizing muscle fibers bereft of nervous innervation, are encountered in active disease
as necrosis engulfs the motor endplate or separates the endplate from other portions of the muscle fiber. These may be difficult
to see in some muscles, requiring higher-than-usual sensitivity settings on the amplifier.
Molecular
diagnosis- Individuals with Duchenne or Becker muscular
dystrophy can be reliably and accurately detected from peripheral blood samples in nearly all cases. If uninformative deletion/duplication
genetic tests have resulted, direct sequencing of the dystrophin gene is a viable option. Other innovative methods have been
devised for accurate noninvasive diagnosis.
- Currently,
most laboratories use multiplex PCR amplification to examine deletion "hotspots," which account for approximately 59% of all
mutations. This method has a 98% detection rate for deletions.
- Duplications, which account for 5% of mutations, can be detected by several
different quantitative techniques, including Southern blot, quantitative PCR, multiplex amplifiable probe hybridization (MAPH),
and multiplex ligation-dependent probe (MLPA). These techniques are also highly sensitive for detecting deletions.
- The remaining one third
of the mutations are composed of subexonic sequences, of which 34% are nonsense mutations, 33% are frameshifts, 29% are splice
site mutations, and 4% are missense mutations. These mutations can be screened for by using techniques such as denaturing
high-performance liquid chromatography (dHPLC); single- stranded conformational polymorphism analysis with single condition
amplification internal primers (SCAIP) or detection of virtually all mutations (DOVAM), a robotically enhanced multiplexed
method; or denaturing gradient gel electrophoresis.
Histologic FindingsFew muscle biopsies are as instantly recognizable as
those of patients with Duchenne muscular dystrophy. Features of Duchenne muscular dystrophy are reminiscent of a tissue battlefield
after a major conflict, with necrotic muscle fibers littering the landscape. Widespread muscle necrosis leads to angulated
fibers, central nuclei, and considerable fiber size variation, with regenerating cells in different stages of atrophy and
regrowth. Medical
Care and TreatmentSupportive careSupportive care requires a coordinated
and multidisciplinary team approach including primary care physician, neurologist, pulmonologist, cardiologist, endocrinologist,
physical therapist, orthotist, mobility expert, nutritionist, orthopedic surgeon, social worker, genetic counselor, psychologist/psychiatrist,
palliative care team, and school staff (including teacher, counselors, and nurses). Plays a crucial role in maximizing functional status and tone, as well as in
delaying wheelchair dependence.- Daily joint-stretching
exercises prevent the debilitating onset of contractures.
- Night splints can have a favorable influence.
- Judicious use of tendon release surgeries may
prolong ambulation by as long as 2 years.
- Braces, such as ankle-foot orthoses and knee-ankle-foot orthoses, can be adjuncts in prolonging
the period of mobility and delaying wheelchair dependency. Maintaining the ability to stand, even without mobility, delays
the onset of many contractures and scoliosis. This may require elaborate bracing mechanisms and often is poorly tolerated
and expensive. Because bracing delays but does not prevent the eventual outcome, this option is less frequently pursued now
than in the past.
|